1. Home
  2. ALXO vs IPM Comparison

ALXO vs IPM Comparison

Compare ALXO & IPM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ALXO
  • IPM
  • Stock Information
  • Founded
  • ALXO 2015
  • IPM 2005
  • Country
  • ALXO United States
  • IPM United States
  • Employees
  • ALXO N/A
  • IPM N/A
  • Industry
  • ALXO Biotechnology: Pharmaceutical Preparations
  • IPM
  • Sector
  • ALXO Health Care
  • IPM
  • Exchange
  • ALXO Nasdaq
  • IPM NYSE
  • Market Cap
  • ALXO 24.0M
  • IPM 27.9M
  • IPO Year
  • ALXO 2020
  • IPM N/A
  • Fundamental
  • Price
  • ALXO $0.60
  • IPM $1.99
  • Analyst Decision
  • ALXO Strong Buy
  • IPM Strong Buy
  • Analyst Count
  • ALXO 6
  • IPM 1
  • Target Price
  • ALXO $3.30
  • IPM $6.00
  • AVG Volume (30 Days)
  • ALXO 494.7K
  • IPM 32.8K
  • Earning Date
  • ALXO 08-07-2025
  • IPM 08-13-2025
  • Dividend Yield
  • ALXO N/A
  • IPM N/A
  • EPS Growth
  • ALXO N/A
  • IPM N/A
  • EPS
  • ALXO N/A
  • IPM N/A
  • Revenue
  • ALXO N/A
  • IPM $6,344,746.00
  • Revenue This Year
  • ALXO N/A
  • IPM $1,957.49
  • Revenue Next Year
  • ALXO N/A
  • IPM $17.96
  • P/E Ratio
  • ALXO N/A
  • IPM N/A
  • Revenue Growth
  • ALXO N/A
  • IPM 14.16
  • 52 Week Low
  • ALXO $0.40
  • IPM $1.52
  • 52 Week High
  • ALXO $6.08
  • IPM $5.50
  • Technical
  • Relative Strength Index (RSI)
  • ALXO 63.55
  • IPM N/A
  • Support Level
  • ALXO $0.44
  • IPM N/A
  • Resistance Level
  • ALXO $0.64
  • IPM N/A
  • Average True Range (ATR)
  • ALXO 0.04
  • IPM 0.00
  • MACD
  • ALXO 0.02
  • IPM 0.00
  • Stochastic Oscillator
  • ALXO 76.35
  • IPM 0.00

About ALXO ALX Oncology Holdings Inc.

ALX Oncology Holdings Inc is a clinical-stage immuno-oncology company focused on helping patients fight cancer by developing a pipeline of product candidates based on expertise in protein engineering and oncology led by the CD47 blocker, evorpacept, currently in phase 1 and 2 clinical trials. Cancer cells leverage CD47, a cell surface protein, as a don't eat me signal to evade detection by the immune system. The company is developing a next-generation checkpoint inhibitor designed to have a high affinity for CD47 and to avoid the limitations caused by hematologic toxicities inherent in other CD47 blocking approaches.

About IPM INTELLIGENT PROTECTION MANAGEMENT

Intelligent Protection Management Corp is a communications software innovator that powers multimedia social applications.

Share on Social Networks: